What's breaking now, across thousands of outlets.
(RTTNews) - New research from Novo Nordisk A/S (NVO) and Eli Lilly and Company (LLY) suggests that their GLP-1 drugs may slow down certain biological signs of aging by two to four years.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.
It has been organising food festivals featuring dishes made using millets, tubers, and various kinds of leaves in wards and panchayats for the past month
A new study from Loma Linda University School of Public Health, published in the Journal of the Academy of Nutrition and Dietetics, suggests that regularly incorporating walnuts into the diet may…
(MedPage Today) -- This year, California is looking at a way to hold hospitals and insurers accountable for how fast healthcare spending grows.
ROME — Pope Leo XIV underwent surgery Tuesday to remove a lung nodule, officials said, an operation that should determine whether the lesion is malignant and if other treatment is needed.
RIYADH — The Gulf Health Council has warned of the dangers associated with the use of e-cigarettes, highlighting their potential long-term health consequences, particularly for young people.According…
